Literature DB >> 32973697

Probiotics at War Against Viruses: What Is Missing From the Picture?

Santosh Kumar Tiwari1, Leon M T Dicks2, Igor V Popov3, Alena Karaseva4, Alexey M Ermakov3, Alexander Suvorov4,5, John R Tagg6, Richard Weeks7, Michael L Chikindas3,7.   

Abstract

Our world is now facing a multitude of novel infectious diseases. Bacterial infections are treated with antibiotics, albeit with increasing difficulty as many of the more common causes of infection have now developed broad spectrum antimicrobial resistance. However, there is now an even greater challenge from both old and new viruses capable of causing respiratory, enteric, and urogenital infections. Reports of viruses resistant to frontline therapeutic drugs are steadily increasing and there is an urgent need to develop novel antiviral agents. Although this all makes sense, it seems rather strange that relatively little attention has been given to the antiviral capabilities of probiotics. Over the years, beneficial strains of lactic acid bacteria (LAB) have been successfully used to treat gastrointestinal, oral, and vaginal infections, and some can also effect a reduction in serum cholesterol levels. Some probiotics prevent gastrointestinal dysbiosis and, by doing so, reduce the risk of developing secondary infections. Other probiotics exhibit anti-tumor and immunomodulating properties, and in some studies, antiviral activities have been reported for probiotic bacteria and/or their metabolites. Unfortunately, the mechanistic basis of the observed beneficial effects of probiotics in countering viral infections is sometimes unclear. Interestingly, in COVID-19 patients, a clear decrease has been observed in cell numbers of Lactobacillus and Bifidobacterium spp., both of which are common sources of intestinal probiotics. The present review, specifically motivated by the need to implement effective new counters to SARS-CoV-2, focusses attention on viruses capable of co-infecting humans and other animals and specifically explores the potential of probiotic bacteria and their metabolites to intervene with the process of virus infection. The goal is to help to provide a more informed background for the planning of future probiotic-based antiviral research.
Copyright © 2020 Tiwari, Dicks, Popov, Karaseva, Ermakov, Suvorov, Tagg, Weeks and Chikindas.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; antiviral; bacteriocins; gut microbiota; immunity; probiotics; viruses

Year:  2020        PMID: 32973697      PMCID: PMC7468459          DOI: 10.3389/fmicb.2020.01877

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   6.064


  240 in total

Review 1.  Bacteriocins: developing innate immunity for food.

Authors:  Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Nat Rev Microbiol       Date:  2005-10       Impact factor: 60.633

2.  Antimicrobial spectrum, production and mode of action of staphylococcin 188 produced by Staphylococcus aureus 188.

Authors:  Sadia Saeed; Samia Ahmad; Sheikh Ajaz Rasool
Journal:  Pak J Pharm Sci       Date:  2004-01       Impact factor: 0.684

3.  Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.

Authors:  Mary C Rea; Clarissa S Sit; Evelyn Clayton; Paula M O'Connor; Randy M Whittal; Jing Zheng; John C Vederas; R Paul Ross; Colin Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-30       Impact factor: 11.205

Review 4.  Bacteriocins of gram-positive bacteria.

Authors:  J R Tagg; A S Dajani; L W Wannamaker
Journal:  Bacteriol Rev       Date:  1976-09

5.  Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides.

Authors:  A Peschel; M Otto; R W Jack; H Kalbacher; G Jung; F Götz
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

6.  Use of antimicrobial biodegradable packaging to control Listeria monocytogenes during storage of cooked ham.

Authors:  Begonya Marcos; Teresa Aymerich; Josep M Monfort; Margarita Garriga
Journal:  Int J Food Microbiol       Date:  2007-06-12       Impact factor: 5.277

7.  Clinical and immunological features of severe and moderate coronavirus disease 2019.

Authors:  Guang Chen; Di Wu; Wei Guo; Yong Cao; Da Huang; Hongwu Wang; Tao Wang; Xiaoyun Zhang; Huilong Chen; Haijing Yu; Xiaoping Zhang; Minxia Zhang; Shiji Wu; Jianxin Song; Tao Chen; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

8.  Heterologous Biosynthesis of Five New Class II Bacteriocins From Lactobacillus paracasei CNCM I-5369 With Antagonistic Activity Against Pathogenic Escherichia coli Strains.

Authors:  Yanath Belguesmia; Kamel Bendjeddou; Isabelle Kempf; Rabah Boukherroub; Djamel Drider
Journal:  Front Microbiol       Date:  2020-06-19       Impact factor: 5.640

9.  Feline gut microbiota composition in association with feline coronavirus infection: A pilot study.

Authors:  Sara Meazzi; Angelica Stranieri; Stefania Lauzi; Federico Bonsembiante; Silvia Ferro; Saverio Paltrinieri; Alessia Giordano
Journal:  Res Vet Sci       Date:  2019-07-09       Impact factor: 2.534

Review 10.  What makes a foodborne virus: comparing coronaviruses with human noroviruses.

Authors:  Dan Li; Mitchie Y Zhao; Turk Hsern Malcolm Tan
Journal:  Curr Opin Food Sci       Date:  2020-05-04       Impact factor: 6.031

View more
  23 in total

1.  Comparative Analyses of the Transport Proteins Encoded within the Genomes of nine Bifidobacterium Species.

Authors:  Hassan Zafar; Milton H Saier
Journal:  Microb Physiol       Date:  2021-09-23

2.  In vitro evaluation of antiviral activity of Shouchella clausii probiotic strain and bacterial supernatant against herpes simplex virus type 1.

Authors:  Mehdi Gholami Barzoki; Somayeh Shatizadeh Malekshahi; Mohammad Shayestehpour
Journal:  Arch Microbiol       Date:  2022-07-25       Impact factor: 2.667

3.  Anti-herpes virus activity of lactobacillus' postbiotics.

Authors:  Neli Vilhelmova-Ilieva; Georgi Atanasov; Lora Simeonova; Lili Dobreva; Kapka Mancheva; Madlena Trepechova; Svetla Danova
Journal:  Biomedicine (Taipei)       Date:  2022-03-01

Review 4.  The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development.

Authors:  Shima Moradi-Kalbolandi; Keyvan Majidzadeh-A; Mohadeseh Haji Abdolvahab; Neda Jalili; Leila Farahmand
Journal:  Probiotics Antimicrob Proteins       Date:  2021-03-26       Impact factor: 5.265

Review 5.  Mechanisms of Candida Resistance to Antimycotics and Promising Ways to Overcome It: The Role of Probiotics.

Authors:  Konstantin A Demin; Aleksandr G Refeld; Anna A Bogdanova; Evgenya V Prazdnova; Igor V Popov; Olga Yu Kutsevalova; Alexey M Ermakov; Anzhelica B Bren; Dmitry V Rudoy; Vladimir A Chistyakov; Richard Weeks; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2021-03-18       Impact factor: 4.609

6.  Systematic Network and Meta-analysis on the Antiviral Mechanisms of Probiotics: A Preventive and Treatment Strategy to Mitigate SARS-CoV-2 Infection.

Authors:  Sinjini Patra; Shivam Saxena; Nilanjan Sahu; Biswaranjan Pradhan; Anasuya Roychowdhury
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02-03       Impact factor: 4.609

Review 7.  Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review.

Authors:  Mysoon M Al-Ansari; Samer A Sahlah; Lateefah AlHumaid; A J Ranjit Singh
Journal:  J King Saud Univ Sci       Date:  2020-12-16

8.  Assessment of the Safety of Lactobacillus casei IMV B-7280 Probiotic Strain on a Mouse Model.

Authors:  Lazarenko L M; Babenko L P; Gichka S G; Sakhno L O; Demchenko O M; Bubnov R V; Sichel L M; Spivak M Ya
Journal:  Probiotics Antimicrob Proteins       Date:  2021-04-20       Impact factor: 4.609

Review 9.  Oral antiseptics against coronavirus: in-vitro and clinical evidence.

Authors:  M V Mateos-Moreno; A Mira; V Ausina-Márquez; M D Ferrer
Journal:  J Hosp Infect       Date:  2021-04-15       Impact factor: 3.926

10.  Perspective: Nutritional Strategies Targeting the Gut Microbiome to Mitigate COVID-19 Outcomes.

Authors:  Laurence Daoust; Geneviève Pilon; André Marette
Journal:  Adv Nutr       Date:  2021-03-30       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.